Research in this U19 Program is dependent on a system of central, standardized, and innovative analyses of West Nile virus (WNV) infection in cultured cells and in mice. The Virology Core is designed to meet these needs and standards and to provide infrastructure support for conducting WNV infections and virologic analysis for all five research projects of the Program. The Virology Core will be directed by Dr. Yueh-Ming Loo, an experienced virologist, biosafety expert, and a professional in the use of mice for virus infection studies. The Virology core will 1) Produce, conduct quality control, and conduct studies of centralized virus stocks used by the Program, 2) Coordinate and conduct all mouse infection studies within the Program, 3) Conduct in vitro and in vivo virologic analyses for the Program, and 4) Conduct and coordinate biosafety training of the Program staff. The Virology Core will be located in a centralized facility containing a suite of biosafety rooms for tissue culture and infected animal housing under and work under biosafety level 3 practices. The Core will work closely with Project Leaders and staff to design infection studies and conduct virologic analysis in support of the proposed studies. The Core will provide services of virus and virus product quantification, virus construction and characterization, serologic analyses, molecular diagnostic and quantification analyses, in vitro and in vivo infection support and analysis, and animal monitoring, clinical scoring, and the harvesting and possessing of tissues and cell samples. The Virology Core will interface with the Administrative Core to maintain records and training of personnel, prepare reports, and to communicate with Program staff.
Reliable virologic analyses are essential for understanding mechanisms of immune control of virus infection. The Virology Core wills serve as the central and essential facility to conduct virologic and infection analyses within the proposed studies of the U19 Program, and will contribute to a greater understanding of flavivirus/host interactions that control infection and immunity.
|Pinto, Amelia K; Ramos, Hilario J; Wu, Xiaobo et al. (2014) Deficient IFN signaling by myeloid cells leads to MAVS-dependent virus-induced sepsis. PLoS Pathog 10:e1004086|
|Ireton, Reneé C; Gale Jr, Michael (2014) Pushing to a cure by harnessing innate immunity against hepatitis C virus. Antiviral Res 108:156-64|
|Graham, Jessica B; Da Costa, Andreia; Lund, Jennifer M (2014) Regulatory T cells shape the resident memory T cell response to virus infection in the tissues. J Immunol 192:683-90|
|Hyde, Jennifer L; Gardner, Christina L; Kimura, Taishi et al. (2014) A viral RNA structural element alters host recognition of nonself RNA. Science 343:783-7|
|Zhao, Jincun; Li, Kun; Wohlford-Lenane, Christine et al. (2014) Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci U S A 111:4970-5|
|Hussmann, Katherine L; Vandergaast, Rianna; Ochsner, Susan Park et al. (2014) In vitro and in vivo characterization of a West Nile virus MAD78 infectious clone. Arch Virol 159:3113-8|
|Suthar, Mehul S; Pulendran, Bali (2014) Systems analysis of West Nile virus infection. Curr Opin Virol 6:70-5|
|Diamond, Michael S (2014) IFIT1: A dual sensor and effector molecule that detects non-2'-O methylated viral RNA and inhibits its translation. Cytokine Growth Factor Rev 25:543-50|
|Thackray, Larissa B; Shrestha, Bimmi; Richner, Justin M et al. (2014) Interferon regulatory factor 5-dependent immune responses in the draining lymph node protect against West Nile virus infection. J Virol 88:11007-21|
|Durrant, Douglas M; Daniels, Brian P; Klein, Robyn S (2014) IL-1R1 signaling regulates CXCL12-mediated T cell localization and fate within the central nervous system during West Nile Virus encephalitis. J Immunol 193:4095-106|
Showing the most recent 10 out of 38 publications